-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 J2gL/ZLJk9aLT7ogDpWSnJlIkKtI5uP31uOMZVKmO4UPXd9XaJwiTku9nTWwBDCY
 c9qg0ZGOsK3sDQDUMenaoQ==

<SEC-DOCUMENT>0001193125-07-132638.txt : 20070608
<SEC-HEADER>0001193125-07-132638.hdr.sgml : 20070608
<ACCEPTANCE-DATETIME>20070608170030
ACCESSION NUMBER:		0001193125-07-132638
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20070608
DATE AS OF CHANGE:		20070608
EFFECTIVENESS DATE:		20070608

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYO CELL INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000862692
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SERVICES, NEC [8900]
		IRS NUMBER:				223023093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23386
		FILM NUMBER:		07910474

	BUSINESS ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
		BUSINESS PHONE:		7277230333

	MAIL ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG. B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ddefa14a.htm
<DESCRIPTION>DEFINITIVE ADDITIONAL MATERIALS
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Additional Materials</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>(RULE 14A-101)
</B></FONT></P> <P STYLE="margin-top:16px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section 14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Filed by the Registrant: <FONT FACE="WINGDINGS">&#120;</FONT>
&nbsp;&nbsp;Filed by a Party other than the Registrant: </FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Check the appropriate box: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B> </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#120;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Definitive Additional Materials </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CRYO-CELL INTERNATIONAL, INC. </B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"
ALIGN="left"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate
box): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#120;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">No fee required. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was
determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the form or schedule and the date of its filing. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Amount previously paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Form, schedule or registration statement no.: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Filing party: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Date filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g45580logo1.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">June&nbsp;8, 2007 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Dear Fellow
Shareholder: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Cryo-Cell&#146;s 2007 Annual Meeting of Stockholders on July&nbsp;16, 2007 is fast approaching. At the meeting you will be given an important
opportunity to cast your vote in support of your Board of Directors and their role in continuing to build on a solid foundation for what we believe will be significant and enduring success. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Your Board of Directors has nominated for election six highly seasoned professionals &#150; Scott Christian, Andrew Filipowski, Anthony Finch, Gaby Goubran, Jagdish
Sheth Ph.D. and myself - all of whom share a deep commitment to serving your best interests as investors in the business of regenerative medicine. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">This
year&#146;s meeting is of particular importance because a group of shareholders led by David Portnoy, a dissident shareholder, has proposed a slate of hand-picked nominees in opposition to the slate nominated by your Board of Directors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>CRYO-CELL&#146;S BOARD IS EXPERIENCED, FOCUSED AND INDEPENDENT </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Your Board is comprised of seasoned executives, who are well-respected, and bring proven leadership and business acumen to Cryo-Cell. This Board led the unprecedented turnaround at Cryo-Cell that resulted in nine quarters of profitability
from Q104 through Q106. As successful executives / professionals and as independent directors of Cryo-Cell, your Board has been instrumental in guiding Cryo-Cell to achieve product and service diversification by becoming a global leader in
innovative stem cell solutions, particularly as related to prospective applications in the vast and emerging field of women&#146;s healthcare. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">We urge you
to re-elect the Company&#146;s current directors because the Cryo-Cell Board is diverse, focused on performance and above all, committed to representing the interests of all Cryo-Cell shareholders. </FONT></P> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Scott Christian</B> has more than 27 years of financial management experience&nbsp;with companies such&nbsp;as Automatic Data Processing, Ceridian Corporation
and Norstan, in successively expanded roles from Senior Vice President of Finance through Chief Financial Officer to the CEO level.&nbsp;He brings to the&nbsp;Cryo-Cell boardroom&nbsp;his experience in global communications solutions and services
and his deep knowledge of financial management. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Andrew J. Filipowski </B>is an entrepreneur who has founded several businesses over the past 20 years. In addition to his entrepreneurial vision, Mr Filipowski,
who owns in excess of 6% of Cryo-Cell&#146;s outstanding stock, brings to the Cryo-Cell boardroom the perspective of a large shareholder. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Anthony P. Finch</B> has over 25 years of experience in cell separation and cryopreservation. Currently, Mr.&nbsp;Finch serves as Chief Scientific Officer of the
Irish National Blood Centre and national Tissue Typing Reference Laboratory. Most importantly, he has over 12 years experience in cord blood processing and pioneered the fractionation and isolation of cord blood stem cells for small volume cryogenic
storage. He has established several cord blood stem cell banks in the United States, Europe and Asia. As an independent director to Cryo-Cell, Mr.&nbsp;Finch brings his wealth of experience and expertise in cord blood stem research, management,
organization and processing. He is a Fellow of both the Academy of Medical Laboratory Sciences and Institute of Biomedical Sciences, and is a member of the Cord Blood Stem Cell International Society. </FONT></P></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Gaby W. Goubran&#146;s </B>many years of experience at the helm of a successful global provider of business development services to multinational companies in
diverse industries makes him uniquely qualified to contribute to Cryo-Cell&#146;s emerging globalization strategy.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Jagdish Sheth</B>, <B>Ph.D</B>. currently serves as the Charles H. Kellstadt Professor of Marketing at Emory University&#146;s Goizueta Business School, where he
founded the Center for Relationship Management and has served as director on several public company boards. Dr.&nbsp;Sheth&#146;s vast business and organizational experience makes him highly qualified to advise Cryo-Cell&#146;s management team on
strategic marketing and sales issues along with compensation and governance matters. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Mercedes Walton</B> has over 30 years of corporate management experience with significant senior executive expertise in the creation and implementation of
innovative commercialization strategies for a variety of enterprises including AT&amp;T, Applied Digital Solutions, Inc. and Digital Angel. Her vast and varied experiences in the global business community&nbsp;along with nearly seven years in the
stem cell preservation industry make Ms.&nbsp;Walton&nbsp;highly qualified to both lead your company as CEO and Chairman of your Board of Directors.</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>RISKS OF ADDING MR. PORTNOY AND HIS NOMINEES TO THE BOARD </B></FONT></P> <P
STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">In sharp contrast to the Cryo-Cell Board nominated slate, the Portnoy Group&#146;s nominees have no relevant indicated professional experience in the stem cell
preservation industry, business of regenerative science or relevant public company operating experience. The Portnoy Group consists of a hand-picked group of individuals who appear to have long-time personal and business relationships with David
Portnoy. The group consists of Mark and David Portnoy, who are brothers; Harold Berger, an accountant who as part of his practice provides accounting services to Mark Portnoy and certain entities controlled by Mark Portnoy; Scott Martin, whose
previous professional experience includes senior management positions with a manufacturer of water heaters, central warm air furnaces and air conditioners, and swimming pool heaters and commercial boilers; and Craig Fleishman, M.D., FACC, FASE, a
cardiologist. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Your Board believes that the Portnoy Group does not provide Cryo-Cell or its shareholders with any strategic direction for the Company.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>To Protect Your Investment, We Urge You To Sign, Date And </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Return The Enclosed WHITE Proxy Card Today. </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>THE FUTURE OF CRYO-CELL IS BRIGHT
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Cryo-Cell has an exciting future ahead. My letter included in the Annual Report&nbsp;describes exciting developments that bring us to the forefront of
innovative stem cell solutions in the expansive arena of women&#146;s healthcare. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Your vote is very important to us, no matter the size of your holdings.
To vote your shares, please sign, date and return the enclosed <B>WHITE</B> proxy card by mailing it in the enclosed pre-addressed, stamped envelope. Alternatively, you may be able to vote by internet or phone by following the instructions on the
attached card. If you have any questions or need any assistance voting your shares, do not hesitate to contact Georgeson Inc., who is assisting us in this matter, toll free at 1-888-605-7511. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">We appreciate your continued support. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">On behalf of your Board of
Directors, </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">

<IMG SRC="g45580sig1.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Mercedes Walton </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Chairman and Chief
Executive Officer </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">If your shares are registered in your own name, please sign, date and mail the enclosed <B>WHITE</B> Proxy
Card to Georgeson Inc. in the self-addressed, postage-paid envelope provided today. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">If your shares are held in the name of a brokerage
firm, bank nominee or other institution, please sign, date and mail the enclosed <B>WHITE</B> Voting Instruction Form in the self-addressed, postage-paid envelope provided. Remember&#151;only your latest dated proxy will determine how your shares
are to be voted at the meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">If you have any questions or need assistance in voting your shares, please contact our proxy solicitor:
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g45580logo2.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">17 State Street, 10th Floor </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2">New York, NY 10004 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Banks and Brokers (212)&nbsp;440-9800 </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Stockholders Call Toll Free (888)&nbsp;605-7511 </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g45580logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g45580logo1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`,@"M`P$1``(1`0,1`?_$`,L```$%`0$``P``````
M``````D`!@<("@4$`0(#`0`"`P$!`0$`````````````!@,$!0(!!PD0```&
M`0(#`P8'"0L-`0````$"`P0%!@<`"!$2"2$3%!46-C<X.3$B-&0U9AA!43)C
M5656%WA2(U,D="6V9[=H&6%QH6(S0T14U);6=Y<*$0`!`@0#!00$"@@&`P$`
M```!`@,`$00%(3$&05%A$A-Q@9$BH<$R%+'10E*R(S,5%C:2HC1TA$8'".%B
M@F,E-?)#&`G_V@`,`P$``A$#$0`_`-E&]_>G0-E6*_/2RH!8KG8E7<5CBA-W
M96CNSS+9`JSER\="14T96H1-4BC]YR'[L#D3(4RRJ91TK9;7;D_TT8-C%2MP
M]9.P1DW>[,6BFZKGF=5@E.\^H#:>[,P*JE[6.H;U"XQ#)>YW/LWM\Q-:4@DZ
MOB>H1SQ@^7A7("K'K*4YM)Q2,:R<-S@**\Z[D9-5,0.=`A3%X[KM=:+0KHT3
M0=J$X%9,\>W']4`<86V;;?+ZGWBX/EBF5BE"1C+9Y9B0W<Q)X0]ENA15*ZF$
MQBS=-EVFWAH45H^?<1D,=`'A`YTQ4&MKU>80(=<.(F3=B8H#QX&$.V(:H<7Y
M7V&U-;IGUS'HB8Z-:1YJ:I=0]L,AZI'TPQ:AO*W@=.S,-=PGOS>'RMABU+=S
M5<WM@5D9-C&I.$VZ\ZRG@:-7UF8PPN4S2T7)I#,LTCE61563[LJ\KENM]XIU
M5-J'3J4YH]4MD]A&!R[(&KK=+%5)I+U];2*R<S,M\\S+Y0/F&8)VZ'H^08RS
M!E*1CQM(1LDT;2$>_9+)N6;YB\1(X:/&CA$QTG#9RW4*=,Y1$IRF`0'@.E$@
MI)2H24##TE04D*29I(F#'KUY'L+1!"T00M$$+1!"T00M$$<.S6:`IE=G+=:Y
M=C`5FM13^<GYN37*VCXJ(C&RCQ^_=KF[$T&S9(QC#VCP#L`1[-=(0MQ8;;!*
MU&0`VDQPXXAILNN$);2"23D`,S&?"4W7;V>I9DJS8[V4.7&"=OE5>^`L.8I(
M%8J>?MU?D[F2G$F[J2BY"6;AW[.#ABD?D0.!WCI,AN!&T4%LLS*7KE];5J&"
M!B.X9&6U2L-PA'5<KOJ"H4Q:/J:%)D5G`GM.8)V)3C+,P_DNA-3I\AI7)FZ7
M+]PN;HH*O9Y**@TDC/#ASJ'3"PKVB65(5<>("=YS&X<>P1[(OQ0XCRLL-I;W
M3/JD/1$XT:TOS5%2ZMT[9#US/IB+\BX/Z@W3'C!RI@_.$IN)V_5@Q7EQH%Q8
MR#T\!!I'3,[>2=87D)59G"II!P6DX!ZU7:%`55FX(%.8)V:JTWM70JF@S5JR
M4-IX'#'@H&>PSBM44=\T\GWFC>+]"GVDJG@.(F<.*2"-HE!D]GF[*@[QL/1N
M4:6FI$2+=R:"O%,>.4G,I3+6V017=1;A9,J97L>Z07(X8O"D(1TU4*;E(H"B
M2:Y<:!VW5!8<Q3FD["-_QC88:[5<V+K2BI9P5DI.U*MW9M!VB+5:HQI0M$$+
M1!`+-EN6\IVGJI[U\>V7(UUL%#JK+(9JS39BQRDA6:^9ED2F,F9H:%<N5&$>
M9JS=*))BD0O(FH8H=@CIHN5.PW8J9U"$AU13,@"9\IS,)MHJ:ES4E8PXXM3*
M0J2220/,G(;(J,GG[.@]7YWC4<PY*''9=U,=7RT;SQG/-0L">!E%CPP07C/)
MX1AE4RF%'D[L3``\-7_=*7\/=?IHZW0GS2$YSSGOC,%;6?BDT_5<Z'O('+S'
MEE(X2RE$G1L*COXZP=P3MY$YW#VT]HY180+D2.8=ZK0I)E&-&BR!R';.4I[*
M,DX?N"&`0<LXXJ)^)"\`A*C:M/)+>%14;=OFQ]"1+@3.+"4"]ZI5U?-2TPP&
MSRF0\5DD[P)1H^TG0^PM$$4QWZ;4DMX>WFP8K8+P45=V\G#67'EEL)701U?L
MD6]3*NJ[6CVCZ138RD"N\9+@DF<1*X`1*/*'#2M5?]W5@?,RU(A0&T'XC(QD
MWJVBZT*J82#P(*2<@1V8R(F.^*86[.N9^F#M<VCXMO4-2<T7"4NR^'W<U'V2
MQ1D4QJZ#UPXJSEDL_K_E%Z\B:^Y;LS)*(I$X-PY3B';K2;I::]UU0^T5--A/
M/*0)GMV[3CWQDN5E7IZW4M,\$.NE?),$@`;,Q/`2'=#TW5]4V$Q'DYYM^V]8
MGLFY7.<8H=I8(6KA(*5^JR1.3O8AXK!1<Y,S<VRY@!VW;()H,S"!%G)%@.D6
M*@L2ZA@5=6XEFE.1.9&_$@`;IY[!$URU&BEJ#0T+2JBL&8$Y`[L`23O`RVF<
M1C9.IKN,PE!;:K1N8VQQ>-H'-=VLM5NBB\K9(2;QTU@+8RC0D#P,NP>G>@\J
M$FG+(]ZNAWY6[@H%+R<=3(LM'4J>11/E:VD@IR(5,3S'$2\(K.:AKZ-%.Y<*
M<-H>60K$@HDJ61'S3/,9&#:)J$5(15(Y%$E"%4343,!R*$.`&(<ARB)3$,4>
M("'8(:6H;\\1E#:N]OA,?4RV7RRN2LJ]3*W-VF<=&$H=Q$P$:YE'Z@<P@`G*
MU:FY0^Z;@'W==MMJ=<2TC%:B`.TX1&\ZAAI3SADVA))[`)F!5X;ZJT'+;7;;
MNIW!TF.Q74PO3VBXHJM;FW5GN&4).*8).I-*)82+&%1*9L[<"@HKS@T;^%<'
M65(4I>.[4V)2:Y-#2*+CG+S*)$@D$X3S^/$2$+=+J1"K<JY5R`VUSE*$@S4L
M@8R!E\0D9F(<J^^3JA[CV?GMMKV9TF`Q<^$SBN363YA8KR?CQ,)4G3*1F;9C
MUI*(*`7B"K)DJV$>(%6.`<=67+98Z,]*MJ5%\9A(R/8`KTF?"*C=XU%7CJV^
MD0FF.16<QP)4F?<)<8[%7ZJF9<(9#A,;=0K;<ZPBC8E>XBLGT[Q\A4@*F8B2
MT@X8*/;"VE8ELHH4SM>+E':[0@\QVO+VARY8J:J9+UH>ZLLTG/U2.Z8$]\=M
MZDJZ-\4]\IRR%9+3BGUS&\@F6Z.'UM\_O4L*X=P9CB60DS;BYQ*<>.(9Z1PA
M8:1`FA5H"/;.6ISHNXJU6F>CE2G()B+)-!#B)3CQZTU2#WERJ>$NB)8[%&<^
M\`'QCC5]:KW1JCIS/KJGAM2)2[B2.V4%<VJ;?ZWMBP-CW#M<:MTSUV$;+6>2
M1(0%K'=9%%-U:[$\5*4IW"TE+G4[L3"84FQ$DBCR)E`,&OJUUM4NH7M.`W#8
M/#TPRVVA;MU$W2M_)&)WJ.9[SZ)"+#ZJ1>CSNVC5^U<L7S9!XR>MUFCQFZ13
M<-7;5RF9%PV<H*E.DN@NB<2G(8!*8HB`AP'7H)!F,"(\("@4JQ!@4NQ/8'DW
M9IG_`#W96=VI<A@')Y'Y:E28MS8C6>$&.M2TE1U)=![#MH4586LRCU@J=%RH
M8W,GPY@`>&[=+JQ<:1I!2H5:,R92,QYI8SQ(!RA:LUDJ+37/N!:#0N3Y4B<Q
M)4TSPE@"1G'1WB]36#P+D)GM\P?CJ4W";CI,[5J-,@%'9HBLOWZ)73&.F5(E
MI(2LK/+,S`N:.9IE%!N8%'"Z`"4#>6ZRJJF35U2PS1C:<SQ$\`.)VY`QU==0
MHHGQ0T;9?KS\D9`[`93).V0V9D1`CS<WUG:W&&O,[LPQ3+UE)/QSJJ5]^=Y;
MTF(@*ADD8V*RE-SIGB20?@$9.50'_=&'XNK0HM.+5TD5+@7O.7CR@>D12-PU
M8VGK+I&BWGR@^;P"R?0>R+K;(]_V--YT3.1D?$2..LNTH@#><5V%<JTG'(E<
M^!4F(1X+=DI,0B<@'AUA.W;NF3D02<(IB=(RF;<[2];5!1(73J]E0R[#N/H.
MPQKVB]T]V2I*06ZI'M(.8V3&\3PR!!S$#@V'^^"W[?R')O\`:=1=;-T_+U+V
MI^B8P++^::WL7]-,4L3]]H]_;`C/Z.RVM'^6?X?UB,D?F\_O0^`Q;_HJ\%MP
MV^MU*]MC-.P0+F7'B[Y%;UDT\D`B(`<0%Z1+G[`^,`:S]2?LE*$^Q(_13&KI
M+&NK"KVYCZ2XT4Z4(>H6B"%H@@!?7M=OH_&6VB0C#J)RC#+\T]C%$>'?)R32
MK'<,%$N8#%[TCM,@EX@(<P!IKTJ`7GPKV2V)]DX2M:$IIZ=2?:#IEVRP@ENR
M;:K4]KN'H2+28MY#*EP9-[5F7(#Q,CBR7&^3A?*TZ9]+*\[M6*C9)VJBS0YP
M3(F7O!**RBISXMSKW*ZH*B9,),D)V!(P&&\[88+1;6K=2A($ZE8FXK:I1Q..
MX'(>N<,?J;;>/M';0,EUR.8`^N-):!DZC$*0#.%9VG-W3M[%M^!3*&4L%:5?
M,"D#\)1R0?N!J6RUGN=P0M1DVKRJ[#M[C(Q#J&A]_M3C:1-U`YT]J=G>)COC
MF]+;<']H;9UC>4DG_C;ACI`<5W,ZAP%TK(5!LU0A9-P`B*ACS53<,'1SF#XZ
MRBGPB`Z]OE)[I<5A(DVOS#OS'<9B.=.5WOUJ;4HS=;\BNU.1[TR/;$)]9S,4
ME3=LD1A6I=ZYOFY2[1&/8F,:\1>/*^S>,I&P)(`0>\X2;\\=%F``X&)(B&K.
MG*=+E::ES[)E)43QR'AB>Z*FK*I35O%(U]M4+"0-LLSXX#O@:]"V^0N:^H-A
MW9I-B6;PCLEQ=&L[-"%%0T39K-#1L):\FOWC<QBE.%]S!;D6[X1X&5C6@)=F
MMIVK536ERXIPJJE9D=H!F$_HH$QQ,+[-"BKOC5I7C1T;8F-A(`4L_P"I:I'@
M)1J?;MV[1N@T:((MFK9%)NV;-TB(MV[=$A4T4$$4RE32123*!2E*`%*4```X
M:1223,YQ]'``$A@!%9=X^!:1N.V[Y)QS=D621%*])359L#I$#KU"X0[%R[KU
ME9*E34<(F9/2@1<J7QG#115`>)5#`-&Z:LM^A;35ZONZRW9[=2NU%01B>BT@
MN.`"8FKE2>43Q5*.%V)S4JD61A(55U#B4-SV.*,D&>P3./"<!*K>QB;6J&U^
MYWZZ6JTQNV-_#>1G*3.-\EOJZQR"CD!Y64XUT47ODMJZ!1HQ5.Z[U-F5(HDY
M4RD#\\F__P!!?ZPNT-1_5)K0=&/Z&.OE*E"I>^\@Q[/7Y_V<N\GG+73"29I"
MA/FC[*/[<=*I<I=-/W]Y6MF$`@=-'NQ5/GZ?++J<O-Y0KFF!C(RY8TCQ<DTF
M(V/EF"O?,9-DV?LU>'#O&SM$BZ)Q#MX"9-0.(?<'7Z":?OEMU/8J/4EF<ZMI
MKZ5JH97\YIY"7$&6PE*A,;#A'RBNHZBW5KMOJT\M4PXIM8W*02E0\1'NUKQ5
MA:((C+-.0D<2X@RCE!PFFLGCW']NN0(*B()N5J[!/I1NU,(<!X.G#8J?9V_&
MU/3,^\5#;`^6L#Q,HKU;XI:5RI/_`*T*5X`F`J=&&E4H*9DW=ME6SUI]FK,5
M]M#!*:LDU%IS4=`-'Q75B=-0>NR.&B]MMSER=R;E`3MV;8I1Y`$!9-1NN]1%
MO82H4S:!@`93V>`E+M,*.DV6>DY<ZE235NK(F2)@3QS^<K/@!!Q_UBX^_3JG
M?]SPG_7:6.B[\U7@8<>NQ\]'B(`5OD<4W;-U#MIV['%,U`(H97LWF9F*/J\G
M'N$9?^<8&MSTM)M8]95,J\]4[20RASE`%7D2DN/%;F,+7:PY6VA^@?!FVF:)
MC+`D`=A'@2(2KP6K??::YTQ3)Q7*X`<\0"3+>D^*0<XZ.P_WP6_;^0Y-_M.H
MNO+I^7J7M3]$Q[9?S36]B_IIBEB?OM'O[8$9_1V6UH_RS_#^L1DC\WG]Z'P&
M+7XXE4-CG6*R55K:*<%C/=6@X7K4NYYFT2F[OTHC9*TJ593E2*1GD-C)01C"
M/!(SLAC"!1XZH/)^\].H6WB^QF-OE$C^K)7=&FPL6?53C3OEIZG([/,9C]::
M>^-'.D^'R%H@BAW4ISXGMZV?Y6LS&>7@+I:HDV/,=N8]XJPF`MMN(HP3?1#I
MLHFZ;.X"(\7)=\F8ID@:<P"`\-:MFI#5W!M!$VTGF5ND-_:9#OC%O];[C:W7
M`KE=4.5,L^96$QV"9[HS_P"Y>(R:VZ?&PJPY>M=PN-PR+GBS9!,^O4W+V";:
MUVQ,@"J,1>SCET\(R4K3-JZ32`P$+XD1`.(CQ:Z-3!NU4BF2E+:&@GR@`3&>
M7&8[H2J]-0+)1+JE+6ZX\53423(^SGPD>^->!0`"E`.P`````^``X:^?Q]/A
M"`&`2F`!*("`@(<0$![!`0'L$!#1!&?_`&AD'9/U/,\[4'?&-QAN':#D3$R2
M@BDP2D$R2=G@V#,RO`O!"+5FX8>7M45BFY>WXH:;+A_R5D:KQB^R>5?P'T\I
M[S"1:_\`B-1/VTX4[_F1VXD#PYD]PAQNTOMC]8=%`?YQQ9L8JB:RWX0L5LDE
M7*N0@\>=(7R-UDB<0^$P5H?O:X!^[M/3R?JE?J_^/THD(^]=52SIJ-/=S_'S
M']2&-MF=DQ5UMMTE1L_!H]RS7K:YJJBX]V5Z:71HF2V";<QA`%16@XUYP`/A
M,V,`=H<-2UHZ^FF'$9-J$^[F3\)'C$-O(IM75#3F"G$JY>,^5?P`^$:%]*,/
M,-6]+P#2DV]W:UR-*PSK,Z]L+M0Y4R-(1I&.G,H[,H;XJ8-F21S\P]A>7CK#
MU-IFVZTT[7:0O"5+M=SI':5T)P44/H+:N4F<E`*FDR,E`&+5#<W[-6-7>F(2
M_2N)=23D"@\PGPPQX1G;C=\=EF]F%WSC7*#<G6.Z9>8W'<M"+*,`3;STW'HO
M8]^K.I'$/-!NM(LFSMUX8KE%P^23!$>(G+^=2?[!O[@:=L?T53K6T#^BKKI7
MU>F_[_[MS8MBFY.EU^28!Z_3P)YI81]C_P#HC0SU$K72;)6'6+<D<O,WT.H1
M@OJ<W-R3E/ZOFQ'E@Z.UO+=,SEM_Q5DNAJ(%@9^H1!31R2W?*U^8CFJ<=/5I
MZ(\%"OH&7:K-E.8`$XI\X?%,`C^C]ETI;]"V:CT;:4%%IM=*U3,`XGHLH2VV
M2<)DH2"3M,X^)&].:C<7?7U!535+4XN7SUDE8[E$B)]UI01^2ZZ#5!9TZ62;
M-FR2B[APNH1%!!!$@J*K+*J"5-))),HF,8P@!0#B/9H`),AG'A(`F<HRV5'(
M.7]ZV8>I;=JW?\A3&"*Y@3-C.C4X]DGU:*Y>24,:N8](TK)GIH9)[,055D9-
M,I4><JRH'_"-Q%Y<:I[;3T32T(%474<QD.;.:L<\"0(^<M/U5WJK@\VMPT:6
M'.5,SRXB2<,L0DF/?TV.G#M+W@;;4,FY"5R"I?8V[6FIV5&N7-")CT/)ZC.1
M@Q)&C$/%&_?UZ6:G$PG'O#\PA]X.;S>*^WUG19Y.D4@B8GP.,]X,=6"PVRZT
M'O#_`%.L%E)DJ0PQ&$MQ$7^_P--CW[G,/_T-#_Q[63^)KG_M_H_XQM_@ZS_[
MOZ7^$1/?>F7TN\!6O'D9D;)5\HUJNDZS#'\/,Y-Y'UGEXV7B$4&T<S:UE59R
M/E62:(\/B@8ZP%`>(CPL,WJ]U3:U,H0I"1YB$Y"1X[IQ6>T]IVB=;34.+0XM
M7E!7F01EAO(AG;#_`'P>_7^09,_T9-HH:DNGY>I>U/T3$-E_--;V+^FF*5I^
M^T>_M@1G]'9;6E_+/\/ZQ&2/S>?WH?`8/EO[V+U/>QC-I%"_;U/*U*,\D<9W
MLZ*JB3%T[(D+ZNV`K4/&.:M.';)"MW7%=HNDFX1`3$,FJJVJZ.6Q_FES,*]I
M/K'$>G(PZWNS-7>G"9\M2C%"MV\'@?$&1'$:^/\`J';N-C[5EB7??M]OMSA:
MZ1.*@<UU3NGSJ6BF8`BV.]G50+3[J<C<A>5R9]'20E`/%(G6$QQV7;1;[F34
M6MY"5'$H.P]F:?`C<90OL7VZ6<"EO3"UH3@'$XS'$^RKMF#O$XF*=Z[VUXL:
M8*-C3.-SM"I0(PKJT#6(-)RY,`<B*LDE:9Q=,@G'@(HM'!_O$-\&JR=+UT_K
M5M)1OF3ZA\,6UZSMW+]2V\MS8)`>F9^`Q7RI;>-V75+S15,Q;N*K(X6VQ4AP
M+NHXK<I2,1(3\>LJW<.(J)B9(C6=.:RD02)+6%\BU.JU+W+!(I>`I7'*R@L=
M,JGMZ@[6JS5G+B2,,-B1/'.*+5#<]1U::JYI+-N0?*C$$C<`<<?E*,L,$C=+
M_6[K#U7'.T^*JM;D'3&%S(+=&.KD*\>-XJ,:5Y!LT2!K%M5B,6+=),J9.)2I
ME`H`'P:KZ:6.K4*6H3+>TYX\8MZN;)8IDM))`=R`R$N&0@[X?`'^8-*T.4?.
MB"`D=9;&UAKE<PAO1QN!&60MMF08,'LB"/>\:U,S3)S"+OR<Q0<Q\3=&S=$Z
M(B`'0EG`#V".F;3CR%K=MKV++R#AQ`Q\4S\!"AJNG<;;9NU/@_3K$SP)PGP"
MI=RC$G='G$4I5=N,[G2XE47R'NBO4WE.;D7/-XQ>O'?OV]9!7O`YP(_67?2A
M.T0$DD'WM0:AJ$N5@I6_L6$A([=OJ'=%G2U*IJ@56._;U*RLGAC+QQ/?'+ZE
M6R3)64[#0-V&UYSY.W)X6%BLC%ME&C1U=X.$>JRL26.7>&28+6:ON7#@J;=T
M8$)-BY5:',`@B4W5EN;+"%T%=C1N[?FDX'N.\9$3WQQJ"T5%2XBYV["X,RP^
M<`9B7$8X'`@D;HCK'O6QQC7HHE9W88DROA;+L(0K*R13.G.W\(^D&Y03<NX]
ME*.XNRPY7"H"8&KELJ5$!Y0<+``'&5[33ZU<]`XVY3G(SD?6#V@]T0,:NIVT
M].YM.LU(S'+,3X3D1V$=YB$<];T,Y]2F-=;9]D.(+U#XYN"J,=D[,UX9>08X
M:T=5,[N*7?,E7\77*^Z*01>AXIQ+22`"U0:E!13GM4MMI;,KWVYN)+R<4H3B
M9[]Y.[``9DQ4K;M67]/W?:&EAA>"W%8"6Z>(`WXDG(""]X-V=8JP]M:8[5WL
M6UN5,D*Y*Q>0EI1J5+SYF;00ZEKFW:29A.T4>O%1\(!#]XR110(13F1*?2]5
M7%^HKC7`\K@(*9?)`R'Q[\8:*.U4U+;1;2`MHI(5/Y1.9^+=AN@-S?$N]OI,
MWRSS>"ZS*[F=I-GDSS,I4FZ3Y_.P)``J8.I>/AVSR7KEI8L$B('F6+1Y&22*
M:9G:":A2%28_>+9?VDIJE!FX)$@=A[)X$<"01L,*@I;OIEY2Z))J+8HS*<21
MV@8@RPY@"#M`BQL-UWMK(QX!=,;9TI]D2*)7M?+7:M,$;N2E^.B20/;8E4Q0
M4#E`56R!ONB0/@U25I:NG]6MI2-\R/4?AB^C6=MY?KFWD.;I`^GF'P17#+N\
M[=QU)V3W`^S?!URQ[BFT<8B^Y4MAQCC/X!R)BO8^3M+9,U=J<"[:"(.VK!S)
MRS]'F13Y2'.F>Y3VZWV8BJN+J5OIQ2D8X[P,R=Q,@,XH55VNE_2:*U,K13*P
M4LX3&XJR2-X!*CE!B=E^T"D[/,'L<50RC>Q3<NJK-Y)MBS(B!KC9WS5)J\4!
MJ<51;P,>S2(S8M3&,";5/B;F545,9>N5P=N%47U8)&"1N'Q[3QAJM-K9M5&*
M9'F6<5J^<?B&0&[O@/;BK9^Z06?\A7B@8VL&8]E.6),)24C*V1P[D:+RN%UH
M]!V9!%T,#.U0KU5HV=NDPC9B-[M-59%RF`HL(<I-04B&G5ANY-B0)R5\8.9`
MQ!X9JQ;K=+USCS#:G;0Z9D#Y/Q%,Y`G!0V@Y6E?]='9VG"&=0U?S3-V4Z'\5
MJ"=*C6;Y5^)1`C%:26L9XM,.]^*8Z:BP]O$I3#V:HC3%QYI*+01OYO5*<:*M
M8VH(FE+I<^;RB<^V<HA[;'A[<#OOW=P&^C<O1'^+<38P3:GP3C2:1=MWS]Q'
M*KO*VX192+=E(K147)/#2SR4<-VX24D5!-LGX5$>[LUM126NWFUT2@Y4+]M0
MXY\)D8`;!.>,5;=2UUYNB;Q<$%NF;^S0>&6!QD#YB2!,RE@(^^QJN6./ZN.^
MJ9D*[8(^&D&.20CYE_"2C*(D!5R52%4@82CEHDP>BJDF8Y>Z4/S%*(AQ`!'7
MES6@V"E2%`J!3A,3]D[(+,VXG4]:M25!!"I&1D?.G(Y135.GW#_&A>3GF?;/
M(8[MXUZ$YYLSGD4605Z5*+P);P'DX6@&,`"KWG=@(\..M'J-_AOEYD\WN^4Q
M/,;,XR0T[^+2OD5R>]#&1ED=LI1K&TAQ],C\ED47"1T'"22Z"I1(JBLF55)0
M@_"4Z9P,0Y1^\(<-`)&(S@(!$CE'"CZ?4HEUXV+J]=C7G;_&X^$C&;KM'B/\
M8;MDU>T?\NNRXXH24I1':8C2TTDS2E(/`"'%KB)(6B"%H@AG7K(5$QA7EK;D
M:X5NC5=LY9LG%AM<PQ@H9!W(+E:L6RTC(KMVJ:SQR<$TRB8!.<0`.W4C3+KZ
M^FRE2E[@)F(GGV:9OJU"TH;GFH@#'+$P"#J-;A:KO:NF!MB6V2\1M_\`UAY%
MC)S*UIIKKRQ7(>!A2G51:FF6`JLI%.$8G=S3X$C*)("P:E,;O%.0K39Z-RV-
MNW2M24<B"$@X$D\..`':83+]7-7=UBS6]87SN`K*<0`.(SEBH]@WP?&JUF&I
M58KE.KC,D?7ZI!1-;@V*?#D9Q$(P;QL<U+P``$$&C8A>/#MX:57%J=6IQ>*U
M$D]IQAU;;0RVEIL20E(`'`"0@<67MVVX.MX(JE_Q11Z#>,F36]^[8`;T:94D
M82/MN/J)G3+-.=P<'+C+`E!Y)LU"QN#>,D'AE(I.?<IJ.4"M!.0G$=P_<.YK
M0WLUG.4SC&4H32$@+5CV*P]=+5C3SQ>0L=8L.8HR):(Z]TF7L$(Y)<8"TVF8
MA7\<9S&N(EVW%NY3\0V5*?I*UH]DD=ACA3:%^VD'M$X@F@[D=QT/TS4MV%DL
M^.9W(-OHF.;748.C8+FXZ`I!KA:(&M24:RHL?DR<F\BNVY9DZS%JB]CUG2Y"
M(@'%3B'A))F<3'0`2))$A$J2&>\V5#:;G++DE9I:9NU1<-&U4>7O:9D7#"L0
M#QU7HU1V7%<S<I*SY(;MC3)UT/`.FHO7"?A$^*@".O(]AOXYW39G[K>S#6.;
MA+PIMPP95,ITVX3>!,B[>9IU:+/6LQR[JN3V*K]9GM@L-,BBXZCEV=A9GCVD
MBN]?QZ8F7C5U0((;^WS==,9RR_@+#^5<98J@LPNL,9EG]R]:;0PS*L+D&AEV
MVO\`'MLQG,2R@O'.&\LUG+[^9AW#I)RX,D4K%95.0C9%$.PXXD22I0':8C4T
MTHS4E)/$"'#M^WW(Y9WBY=V[H36*?,$\5D-#;V-5=@XO#>=VX7&.QAGYEDE@
M6;<,1)+7&QMW]32:MV0N82,?+&%8`[Q/C/.)``!(91-&VV:W(3N4\^0N6,PX
M]NU5P[D)GC./B:MA!YCZ5F74MA_#N5&]E>SKC+5V21%@XR(\8"S39`19)!)7
MO"'$Y-$$1'6-R^=LQXIV.QE,DL>8\RANOH<WD&Z7Z6JTC:*Y2Z_2*=$V"RL*
M-1%K/$GF[989FR1[9B1_*&;,(\KYXJ1V9N1NJ00V;!EK.=3P?N?)5:MMYM6[
M';WGG&N$*?>)2F2-2Q;DV4RD;`5DITQ:HV,EG]BI$@O6<XMXR:!I)O$F<FT4
M?(%,V439D[+CA'*5*Y=TS$8::"N8)3S;Y"<2YMEWJM=P5\S81XQ846CXEPSA
M"X6>"L918WK%.3K!9]Q]8SICC*;@7ZL8UDL8RV&$&Q@1232$H*NTUG+1RU5U
MQ$D,;9/OM>[GJWGE>5D<:N;12XV'S)C^,HCQ5\DRP'EV&L,WAJ-OP*3,DH&4
MZ^I4I*.M*2`MD$GJ!!(BB54@:((E/[25\_PU/M?>`K/ZSOL-?:2\E^!D/,[S
M\_4'^L_P'DWRIY5\V?.'][[CQOB/"_%[_G_?-$$7DT00M$$+1!"T00M$$+1!
M`O>L+[#-\]&_2_&_I5]&>E\;_L_G_P#`?C.&MO3W_9HS]E66>1A=U3_TR_9]
MI&>7M#T[H&KT,_6;DCV=/1'_`(#U\_2#3Z%^H/Y0^<^'UM:G^P1]M[7^CO\`
M\V[A.%_1W[2Y]A[.S[3/9_EW\91ILTE1]"@2[OU<X`]$O>M95^'Y-[2&Y+Z/
M^M?\+\Y[[1!'6Z:OK1ZJ7J?]Y7D+U,_1'L_[=/37^MO]+/S]XK1!$,.O<=TW
MX/47B?U:_+_3ZI^KCZU?D3\Z=QH@AT5KV-=P/ML^F-`]O_TH])Z3Z&_53]U\
M_P";1!$W9Q]:V_3Z*]W+C7Y9\C^G=ZWI'\Q_@?Q7B-$$0#7?>F[1_4S[I+*O
MH_[0'KAV\?+OZHOR!^=_*>B"''BSU/\`1M]"/3IIZ+?3/L;;B?H7YS^E_P"/
M\1H@B[V`_6GO.^C/:.K7R#Y5[*^VSZ9_.7[GYIW.B"!+98]W9TU?2?TLQ#[+
M_M2>K&Z>R)]9/TA^H?EG1!$N;:O8'F?VTJUZT_7S[8>-/:O_`+R_Y0_$>3=$
M$0[?O6Y_^A?U.^S5MM]7'I/[.N:O:*_/W_,_4[PNB""!7?VTJAZ(>[XSM]"?
M^TL)>D'U*_('^MY4T00!IK[J^=][C[(53^5>SA[.MT^@_P"ZC^5?S#Y/T01_
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g45580logo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g45580logo2.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`)0"4`P$1``(1`0,1`?_$`',```$$`P$!````````
M```````&!PD*`00(!0,!`0`````````````````````0```&`@$#`P,"!0,%
M``````(#!`4&!P$("0`1$A,4%B$5%S$*02,D&!E1(B5A<9$R&A$!````````
M`````````````/_:``P#`0`"$0,1`#\`L!R7>69;T<G4XXS-8YLZU[2^J$/Q
M/=[+VAR@M+.Y+(52QO;(WK34\A$`T4*PK=''O)7],'#H$M"K1(#4AI8U`PDG
MSH/IX6/*YNH2%,,HP$S)%B1TMQ9+62*S`9!]U3VHWKR;`P\XSGR]T)Q&<(7U
M$(7U[@P''E4VRM(63O97>P5YVKL-'4U_Q.1Z\V#:ZPI>\$4G)JEBBUIAQ:I$
MWM34K60R1E.*!<I(3E"6J2<J3<>H<+H)/>@.@.@.@.@.@SVSV[]L]O\`7M]/
M_/0';/;OVSV_U_AT&.@.@.@.@.@.@.@.@H?_`+-!SD,MN#E:G5EFJE-PR"54
MTMG:ETR,3P-Z=9-=KG)/>B.R([!PI&,WU,"SW\P]L_IT%Y:7SJ$U\V%/4\E\
M:A;.>L+;R'64O3>Q-YR\XLTTE$4K<E"<@Q6:42,02\"R+(09SC'TST#:,6TF
MLLJ?BXI&-C*,DLH&N3-@8RP6Q!GF0!<EIX4J1`8RMSXI<B%BI4+!8"QE!&(S
M/CC'?Z=!#74G)L1O;R)[;:S0JZF;7W4[10ML@LYFR&41&+V9L9?CN]O+.[,T
M?E4E-4"B%65N=%').H^U$`=7)=@HP2PE,/!(P\JE^2Z65GS1/'%S)[)#L11-
MOTBV7#KQ<*A4P/TQK69H621/,OJ28S:))DS3.(XJ01)>M0+%Q>'AO&,A.>>I
M+&$8`<;1'?&6\MU\;C.-6S9^JG2G5.R&^B($MKXU(VV3L-9!*=:XR^Q'^;+4
M"]7$JZ:D9"8+&U-`$JM:6MPI6JL]@I0!NW1R!2GCTY']4M/KYEKC9>M&^+&Y
MQ^DK1EH&LNR:5OB/OC>R8@\P?VQ&UH9[6T[.D386@6JTP'AI<%6<'J%27'<H
M.3YSN=O/#_W!</XTZ^O!WD-!3S5#-FK?G<0K%X=H'(EA$F<G>=$O+5"HZZ.W
MV)NCGH-3:<:)&-P4DY4A-)P8'(*Z:;4\FG'U*N8"ZKUA,ON'1372G&6R=,)3
M;+U6JR7S*SE2&--B]@`[5L@8WXVLE$D>%:I>%R;2U+2D2%ED&9R,7<.J]8XU
M=EZ\9U?;63O:"Y2-H[@UN*V,(G\5EAL?KN`S"40X<_C<7C5+IBQ5DKKJ)Y&F
M;S4#FWKU#DE*-$J4F'F^L`(H=1>1*U2=#R^?K8G:B[55>1ZG;3K*W=$S"V0V
ME[0V19;'S7]<2.CSAA3#K-B?7'*0@:8)#B>2+U33U9N"E.#@D5HB\;-V$X^V
MO:^SMZFBI-H[7I-XO:$0FMIG5C55E)*7J.N$OK2MS*RD9+XHL)*SMHD*=],D
M)RMP<5`U&"AH\>D`H.7*6Y^'NS.%MIW_`)W&FVKK4C]^UQJQ?#\ACCD\0RL'
MB3SR%1Z47RU1)9D]<XL+9`)<!Z2M9HSRPN^<(QY/*!G!@2FQ%?)+?5:^73H=
MO/B_ZF,M2+CV(9'*=5A;L9G5,.[:[!>5S`Z(V8IRK2;LCL8B583-HD):A(`]
M/E*$?IB`#"SGD1E=_P#+%CBCUL?_`(.W4M4SA=NXUZ-R%K=Y>U)A$1TN,4G5
M)+RG<F%C?W0R:M:AZ?5:-:8C3G"3HRBU0!'@#4Y.MM+/XA:YJ7;E),9I>&LW
MYHB-5;,579:]+)IBR1"P"EY#;:U0S<IN0OR*411Y;@%J&1Q,6-3LF5^!>$1P
M`G9#D_F(Y#]D]2;WXDI3J5<DFEU4;T7RD02ZNSH_6S\Q3RNERBE3XFQ0=U=H
M2&1Q)+*6Z>*/56^^-4%A5!,"(/I8#D.]>2X[9O7?079/;&#[1SN,[!T%5K[=
M+2D862$*:24JX6$#XXUTJK:015T->(6ZM91S=E6K6B>O(050518\>E@$1_E/
MFW^"'_*Y\`C?Y/\`[4_RI\#]5?\`#/RC[_X3Z?C[C[K\0^9_U?H>O[CV/\KU
M?/\`F=!S-!]11<2?+3>VXT993PZ"\B$;(;KI>F1O.4(M5=CD#]B0L<IF[>V)
MC#&RE+"=7%V!]\]/*-B<WCTUPTR0)9P@GSGEY437]?.%IV+:=9L%9M#:-\63
M%\E,?%'?8%)QJ0J$2S*LXIQ/4DASA.4E]4]2,6`%!&,00Y"JGP%5E=+URL<J
M^XL\UKM^FJ0VVQBS=>9#:]:OD()F$.5W!(%34X-A#\VHC6]R6LIR9:-&8$I2
M44>$60>/8604G$7KT3QQ<K?*%K-LTS,S,T[<3EKV(U`LJ<MS<")7+$A3"PWF
M21.*2=W)$U*K`B2>?)"W!E"=APSE(>HP3D@(3<A9A/F=6'V0TT[#8TPR1^>&
M>1*YPOA13`615T6^T'IB'*5.+<4(36X2MQ4EH&U%@0%BO`CCPAR0F.$$*]G[
M??7:3\7UJ\@?'O?P@1E_<KW1W[KA,WK.&Z-;!4<_LHHR5(X&]J\E-KR_1(3&
MC+D#648)<TJE@<&E^GD!H@U.47661\GG,!QI5I4'D\55H<Y.FP&UUN-&1J8?
M`#%DUA<EAM4!DB<)C4KM&89K<.`M))HU:%"M`M4``1COD&JD%B5^']W1$)H*
M=0T,/)XYUK4?*Q2ECQ&B'4)<L`-K.???_:RW$`\XQD@1N#<=_P#UZ"9OF'VS
MK75G4=D<+=3,(J2V(N&O-9K<G<EB!MC0>MJFN$EX33B?R*))2E14E0D1E`<E
M2$C"8G]XM)-,`<67DDT(NJ_W:X6*TUS*TOKWF@.8=8`1)76S5"53\UK9U'*Z
M=TQZ%S@D=NQRJ\,N98\<B5FIDYXS#'!M1F>DE5DX+)R4'0?)EH94^ZW!9)M8
M^,L%<OU>Q>+0>>ZRQZHI`UOD*FP:KDI,C51%GD*9Q5IW21RA*6X%9.5J!J5#
MZ;C*LS!HS!X#J;B.M>@[*XXM6S7))7T8F],TA`:>O*&S1JC\8FU5V;4L900F
M9QVQ&"0IT+S%W9.XL0U']<65D].:!0'(BS`CR'K[A[6ZML6ND7-V%I9CDNG&
MQFQ[9K!-%,LC9:^'/<!EC`_FM]W*8^WMQIH*ZQ-(V66%R/`5DAL+"\%FA)P2
M9T%=3?3ARIKC_G^K6W'"I<=FUCL?9FS=606):\P"T%%E02UXA,'0]5*5[:F&
MO<Y"97D58D@UCX)R5N3`4SY-$=DCL4+(=VP36>5\?_[CFX-L[$*,3:Q<C]'N
MT2BEO*?5Q#H#L&ES6SPNJB<OQ@`H8JLE0ZX5'Q\Y<,A.Y^[+2$#&I+&7@'?_
M`'($-E6Y.IE7\>.MR(BRMC=G=A*P/;(TPJ"7%-`:S@2I;(YI;]D+T0ST\,KN
M-C"D)-7K<EA4'*0DIL''Y]/H(].;&(06AKP_;4:_LLZ87XG678Z#UI)5^7IM
MRM9V^!#U?CI+Y+$V%IIL;*<4S,)3D2OT@!#Y9QGQ#G.`GBYKYS"5'$9OJ81,
MHH<7-=4+E3PTPJ1LY@):HQ&5(<IXR("S(7X_`AAQX)?5%Y"QCMWSC'000_D&
M!?\`QU_!_F\0^:_V<>P^'_)67Y1[_P#-ON?9?'_>_=O=^W_F>EZ/GX?7MVZ"
MZ,,`#`#+,``PLT`BS"S`A&686/&0C+,`+&0C`,.>V<9QG&<=`U*6A**0NZ60
M(J5J5(_(%8%Z%[35S$"'5$O*'DPM<C7%LX5"5:`>>^#2Q!,[_P`>@=G(A9_7
M.<_7O]<_QZ!-RF'1"<M>&2;12-3)EPI)6X9Y6PM4B:\+$_EZ"K#>\)%B3"DG
MSSX&8!YA[Y[9Z`C$.B$(;Q-$+BD:A[2,\2H;7%F)KC[>-2,(0#4C1M*5(G&H
M&`&,9'D.19QC'UZ#$IAD.G+>6TS:)1F9-1)^%1+9*F%JD*`I2$`BPJ2DCLE5
MD%*`@&+&!A#@6,9SCO\`7H-J/1J-Q%J)8HG'F*+L:<9IB=FCC0WLC208>+R.
M&4W-B=*C+&:+/<6<`QD6?UZ#Q\UQ7AF,EB@,($$P>1B"*)L&0B,'G_<,6,M^
M<9$+.?KG]<]!2]Y(]J9CO-==L5^\I%:[6&E;8M"G*@H]M3-2IOG$EHF95A2,
MUN:2,CVD61B5V?8&REV,5>UJ2^)5L:@R(IUDZE`L7IDA?02MZH_ML^-JJXTT
MOU_:RU!<EN+8XU-CLVG-;L.HX(402(>8Q!XTN<1K)4-`<>("B428QSD3R<'*
M@PU,6,M&0"TX3==H]K3/^4^OZ/1+V+3AMWI5M&MT6$YN;E'(Z\L-8Q%)?39"
M#G14L.%%F6T#SF@O)9@R@*6HXGR$829GH)H'VGJBE#X.42:JJVD<F,PFP9(G
MZ"Q=W?1X1AP%)@QW7M:A>9A*'&,%^1F?#MCQ[=N@7YB=.<`)9R=.:6#&0@+-
M(*,+`$10B!!``8!`!C)`Q`SC&,?[,YQ^F>W0(B-555L+=%#Y#:TK^)/:LDY.
MK>8Q#(XPNJI.H,`<H(4.+4VI59I)YQ81C!D>0C%C&<XSGZ]`K79I:GYM6LKZ
MUMKVSN1.4SBTNZ%*YMB]/G.!9(6H%I1Z143D0<9\1@%COCH/`B=?0"`EK"H)
M!H="2G$10W`N(QADC8%PR?/T1+`LZ%'A5DGU1>'GY>/EGMV[]!]UD'A+BK4K
MW"&Q->N6Y\EBU;'&94K5BP#!?DJ4GHC#E`O`.,=QBSGMCMT'U40Z(+$;>W*X
MI&53>T8'AI0*6!I/1->#.WJ8;DIJ09"'!GCCR]((._;Z]!H?CFO/+S^`PGS\
MO+S^)L'EY=NWEY?;^_EV^G?H%ET!T!T!T!T!T!T&<=^^.WZ]\=O^_?Z?K_UZ
M"A?NZ54J?:79X_7=?-':M5^Q6PA4Q:Y`T((^5%+#3K:-SMBNJ]^C[W)G:P:3
M>-B<P`+4D4-L9F+;;^"A1-0N!E6'`63M?4G(*.A$BC8R06@G8BF,&7%HA4/A
M"S:-:QY)+PJ`.1+)R@`UNP4.1B,$C:UDB%G&0I@X69`+`20:_P#X6_#%>?V[
M?&?PM]@+^!?$O/[/]M]TI][ZGN/^1^^_>/<_=???\E]T]Q[S^J];H'AZ`Z`Z
*`Z`Z`Z`Z`Z#_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g45580sig1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g45580sig1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`*P"K`P$1``(1`0,1`?_$`'$``0`#``$%`0``````
M```````'"`D&`@,$!0H!`0$!`````````````````````1````8"`0,#`P,#
M!0```````@,$!08'`0@`$1,)$A05(A87(20883(E02,S-1D1`0``````````
M``````````#_V@`,`P$``A$#$0`_`/OXX''&281&3+Y(U1N4QR0.D.=@L$N;
M61[;'5?%7T:),XA99(C0*E"AC=A-ZPD_"94$H[))H!^GTB#G(>R=W=IC[2YO
MS\YM[(QLK>L=GEY=EJ9N:FEK;DYBMP<G)P6&$I$*!"D)&:<<:,)918<B%G&,
M9SP,]'G>2VI3'UUC:S:56UL'3;4E.<P6$HF,*I]?8K.D+&H4N=%P&?#+EUC)
M#TH?4WGKR8\B=\],H5"@L91A@6YU]O:OMFJ8KV^*L5N2R"64P@?6/+TUJF-[
M19+5*6UU9GQG6!PH;7MA>D"A$L)SD80*4X\`&,'I&()CX#@.`X#@.!"EG:_5
MI<CXQ/-DM[M)4\9;7)&QQTV0.[='&YR<U",XR6)D#.J;SBYDB)1X(1N6#O<(
MB#3<$9+$:,60BEDE4XHFXX=44[?W"<5#;H7)KIFPI"/OS"&6%'VI4^JZAL%]
MS@HF4HI+%VY4NC#N?C#H:8VJT2\:H\250<5<'A#@.`X#@.`X#@.!C+8])[_:
MQ16])O&/).TJ=>F(J>V][G8+7ULM^ZJNC*9"X2)SAL0GA,ZAK))&IOR2(#5\
MXV+C$^,@)](R\!!P*T>/V'[&TI0HJ"H]7'9;O5L-(WO;G=G8VXF56\PRC9#>
MQ*&315FL)LCQK"OF%Z*(`K:RVF*$"2(4X$RE:J,2H,I2E821JG<T\\K4&JZN
M[L+BJJ"TXA<W'>)DAJ9U:(M9MZ1NQ9$PU?1ZEO5*SU*>+)VN&AFDN:\*5"8X
M2II;QY.1J%)>0WE``H@H)982R2"2P@```0EE%%%AP$(0A#C`"RRP8Z8QCIC&
M,<#-/Q+(S4VH&%129:3'WW8':F20E0I[`4;K!W[8FR'*+O3`2289[>-N[:>$
M]"$73J2/`@X[8@<#3#@.`X#@.!">Q=YQ;6ZEY[<TN)6.""',^3FN.-10U+_-
M9:Y*"6B&0&+H"0&J'*4SF5+DC4W)RP#&:K5@QTZ=<X#A.FK)LNRZ[P+.WLW9
MYSL`^ENTMG1T?CS5'&6(FRUW6R%LK-N(9TZ1*ZIJT:G$EDPXB*+-<,HN^/&1
M#R+(>)N\TC6:M7!(49(AOU71K-V10XDW"96EE=*K$UHL)J)9Z1Y1GG+HJ$C(
M\8%C)1PP"",`A`$%DHR_))3&X_)V_KA!(V1I?D6!=?5[1W0)W!-ZO4$`NO94
M!Z]0XS_3'`Z91*(W"8X^3"8OS/%HI&&I<^2.22!Q2-#&Q,S8G,5N+J[.B\TA
M$@;T24H1AIIHP@``.<YSC'`CZBK[I[9FL6"Y:'GS)9E8R@QU)89?'\J\-Z\Y
MD=5C(ZDX)7I42].:C<V\TL0322Q9].!AQD`@BR$"OFY[,=N9$-,JR@SG9\J3
M1=XG6P,R;'8ELBNO<5"V$&PXB0JCT"HA_F\V=7!+@AC).(5IVTWWIF>WDH!@
M78X#@.`X#@8G>;C8))75+TK0:9"KD<GVFO&(PU'!VS'=<9W'XBXH)2XP@M,7
MU/\`:SB2E,S,I'_8%$O/R/.,!SU"_P!JI3&=6-?"4%CR5O?+#7CDMO[#V1@Y
M3E#)[1D^3)'84D`K<L!6@C;1D&$#46=Z<HV1O2D8"$)6`X"K7ABJ-!6NB,%F
M`4(TT@V0F5F;.RA6>`P*ES.N:;/$DBJHS"@HM464"OAM!999@C,@P'/08NO7
M@66WILF2P'7>5,-<"(.NBZE".AZ.;#1&8,6V;:(5#`VN(,$_6%)"V8:Z0+3<
M]"DS>TGG&Y"6`6<!/=/UC':5JFN*BB).2(S6D*C4(8RQ",$++=&FE*U)S#!'
M&'&9,/"F]8NHA?4+/Z\"1^`X%<=L]A6_5R@YU<BEA5RYX92V9A@\);S`E+YS
M9$V?6V'5Y#DQPOT3!D$P?$9!Y_07M4PC3\A%@O.,AS.B";O)J.#@V16URON\
M33DZPSJD0OS?71;TH5J3P(HL1)EBY],0-J`PE.(]0,(E)I0S<`+"/!80EO@9
MCFH![K[AD*EA"D>LNA4_">U=1GDM]O[FH6TPLYP`,DSL.D0UI9W<1`<9Z!,F
M2TW`@YRU8ZA0G>&Y;7W!\HVL?COH272Z'P;6Z>UMM!M?*8.K<6U:<FC)A4SC
M\6>'UM5IRT4:(2?'I#$AHAX<'61)L#),+0F8X&QV[<P8X#IUM)+I&O(;6AGH
M&V1G*3\_H-4KA#TWMB$D&`&"/6N;HK)3)R@A$,X\X``XR(6,<"**FVFH6DV#
M3[5&[[LK^&[43ZH*OC;33K]*$0[!>9<V5RU#=D9S44<J4(E"I6W*0IAK!$A7
MG%B+3B-,^G@4%\EEVH+/N([6TQN*G42J)/7BM-0V##3@[8[CV\8XJ=<J1DS:
MG.+RX4[5+2S&3R;!/Z(`)@H!K1%IRA=P/#V8;=Q?'WK$C:Z@V`U\J6`QUHB4
M6KXX%.++$O#8+;*U5RM5)RI*HEDFC=8PJ)O]@.*UV,5)T#HL1L1"@PS`0I0@
M$'<UNT7V%U-KF77U8_DM=:LF-M/R.<7?*K+IW7IPC2J52EY"C1"<Y)+6QL=6
M[YQX>$Y"=+EQ)R3@:5"6$/8+!@--:@C&\T+GR!IN&U=?[TJ%4B=LKY<SUK*Z
M6N!A<RDX1L8`QY#*K#KZ7MRY3C):H03&,U,'.#`8/_X\!<3@.`X#@8J0*$MV
MY7ELLG85P7II!4/CKAZ/7NKF\28E<SK]EK!;ONNWI*1E42:G^1KB-.+8UEJ"
M<]PM<>/&!A$GZ9"5/,79\LC.GRJCJO5G)+FW4L*&:?5<>E]9REK7W(K/;YE)
M34*4H]S4M4:KE$[J%1B8&3$P.AN1EX#ZPAHA6D,8:9J.`UZD/;VZ,U5747AZ
M=5G.&YK1,D(C:%F+4BRK4&!0H4Z%L]><FFB[9>/J'GIG/`^<G?S;:Z9!4ZO<
MND6[*B36/9K+I;XIXQ@:<B1R5^NIR#$K,V_:&-V"$Y:_RYI0+&N%F9)R!MC)
M?R@P9*=C0\"!]S7*Q?'1XL4FAU&VY.+-W+*21_8O;&VVZ>R<YZK)ODMJ1V4R
MYZ=[!"\">(X_VO8RU!$(8U8.*<)"G,5*`$8`$_.0U`QN)NI?<E<KIU](I&G]
M#=8)H\)=A;$M]FE,SM_8=LJ5F5J[_:*0B#$J:6:$,\*>&U6S(W5V7B/<W9,:
M,("2$XBU`5_US\S6Q=L4?;NU,KUIA`*IG=DUU2'C]K*$RYY563>EP34+M[V.
MSF9/"8B,-C-&.T0)\=6YL&A9\I'(L)BS*$8AA#D>N^U[$\@NN\%WBWMU@F=<
M5'$9[NS.:MK6/1&%4Y2]MUL:*`5W7S+>CE(L/EG+H0.P53HXA7J>X!6V%F&)
M"RQ!P6%/='?)[,+0V)VM\@<TF-GV_*!,,[IG7;4&%29R#6T8C;?)%$A)GEH*
ML`(K:D*BBS.QMP,RZ3J`KG!8Y.AQ19F"BBAA]`>B&R.VEW^+]'M/:+)$Y5L7
M.*_NVSJ^AT&90L\?7IR'2:*J:B2`A2Y#`Z%*VUO;R"UHSB_?DF`.$+.1Y,$%
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M1.4@EFRSVM4ESBW_`"$VT]/:98TOR5`).<SL<>0O4?C:+HB;BCQD#+&%S=;7
MZO=;=M-H+^W:K2WISY'YO;;DBA%:4-3=XW'7K/53_"H4S0Q9K@Z_9Y<,`*0Q
ME"!JD4C<W)J5#-0&IE(428&2S`ES819MK/=KM5+OV7T5GU@:LUVWV;*JNHBC
M':/V[:,'V%,-BR*L[$V3:%<AA]?X.*B(W?#6F;EKNSQMP.&-0X*#\DB"$!^0
MNG_(#O!,JIBM]:2R&3ZF2B(6;B)ZY5+>\512N&7^8E1-%3VUM99PG&/1AF:(
MFW.ZYR0H8_F1HFM:1G(LN"OLAP$AP2Y/)SH=9U.Z4M4&GGE1>W75R,S^4R1Z
M5L5/9HV=HGI'%US2];(R!@;(=8%=/0T#E\62YH12\&2"1*#3"S.G`T>;-M-T
M&GLCLOQC6PC2C)$:>JJ#8;7&UQILE`]9H!MS[,:M<C3,XQGT!)*-R,7TXZYS
MP.K_`-*8$SY!FQ]8=\JG(R,83U\LU'LJ2-23`,8$(Q2[U*19;9@G`<]?6`X8
M?Z\#RR_+!X]`X-PZ[-1.)')Q8"K1S^/SVNUZ+.?3C]\@G,3CRQ&'&1X^HP`0
M_P!>!+'\^-*/AON'^5-#_!?BS\X?+_DN+_'?B#[[_%WY(]W\CV?L_P#(_P#@
M_>]>S\K^VZ]WZ>!YFFFI$"TJI%#3$#?)1+^]*9=/IG/IPL3N$TL&?SIY/>I-
M+9.M2)TJ<YP5FF%IR\`!C!21,27U%D&1"#EUCZTU7;%RT)>DY;W9WFNM2N>N
MM3I\/2M/&F>0V*P)8L]R9>PDY"E=G]''B3DB`\[(L)"UJC(0Y$/`@A4W8)8X
M[F72Z:3PQ[5-=*UD7%I1O%*&E2K2+).T29.I<X5JBP.:(11B=38[>E^2FIQ1
MI9J*+9(18SZWCJ4'Y)_%1K):<^M::WXGD-W-LQBD<K:GX#)EA4<A6IE71IM8
MRDL1UG;H*5&E%9NRI_9"W(Z1(S02'UEDIRU9:8@)0@D-%XV=/V:JXW3,;K$Z
M-P5ANBM;_=26R4253([&LZJ)&@E<1>[;FSXYN\RM`!+ZU)33RWI<KP<%,47U
MP6`(,!P)T\3^I,@F,S?9*5<<AK^=S^3VD_:XN-X601K(=/YLM"[S&0BI5I?&
MV++L2>09,<U:%:%4V#7GFFX3!R8+&0DEV\:VB+S2S;KLIUAK%)2K//2K0:Z_
M8FY=&6A!/B25:4$G2GQQP:G,EP$A7G)AXP?VS$IHB!A$2+(.!+*_4759VC5:
MPUWUNHQWB5-",'4\:=JKA+FQUR8=@'?-AC6O95"./'*1EA&:-,`L1IH<&#R(
M>,"X$C**DJI7%)3`U59P`^$3DEQ3S2'FPZ/#B\N(=RLD.I4F8<MWQ;Z!R(%D
M!^%11O=#GH+KC@<O965GC;.UQZ.M+8PL#&W(VAD8V5`E:V=G:6Y.6D;VQK;$
M)1")O;D*0D!1))(`%E%AP$(<8QC'`]GP(ND='4K,)FTV/+:?JZ4V&PDD)V*>
M2.OXF]S-E(2FC.3$-,H<VE4^-Q*<XT0RPDG@"`0LYQC&<YX$H\!P'`<!P'`<
M!P.PI2IEI)B98F(5IS0Y`:0I)+/)-`+^X!A1H1`&'/\`KC.,XX%?_P"(^K'P
MGVW_`!RI'[?[7MOAOQA#?C?9_D'\L?'>T^'[/Q?Y-_SWM>GM_EOW/H[OU<"P
M_`<"E.E?Q/M]I?B/X]^C^9=[^_\`X_\`WKW/E?=L'R'YO^]_W'Y][W_??&_X
D7L>T]E_M=.!=;@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@?__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
